{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:54Z","timestamp":1792783314210,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal De Pernambuco","id":[{"id":"https:\/\/ror.org\/047908t24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with severe obesity. The triglyceride-to-high-density lipoprotein cholesterol ratio (TG\/HDL-C) is an accessible surrogate marker of insulin resistance, but its association with hepatic steatosis and fibrosis in candidates for metabolic and bariatric surgery remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional study included 99 patients undergoing preoperative evaluation for metabolic and bariatric surgery between 2020 and 2024. Hepatic steatosis was assessed by ultrasonography and liver fibrosis by elastography. Associations with TG\/HDL-C were examined using categorical analyses and multivariable logistic regression. Because diabetes perfectly predicted hepatic steatosis, Firth penalized logistic regression was used for the primary adjusted analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included 61 women (61.6%), with a mean age of 37.0\u2009\u00b1\u20099.8 years and body mass index of 40.4\u2009\u00b1\u20094.2\u00a0kg\/m\u00b2. Hepatic steatosis was present in 81 of 99 patients (81.8%), whereas fibrosis was identified in 35 of 98 patients with evaluable elastography (35.7%). Higher TG\/HDL-C categories were associated with hepatic steatosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0016). After adjustment, each unit increase in TG\/HDL-C was associated with higher odds of steatosis (adjusted odds ratio, 2.23; 95% CI, 1.22\u20134.08;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0090). TG\/HDL-C showed moderate discrimination for steatosis (area under the curve, 0.763; 95% confidence interval, 0.632\u20130.868), with an exploratory optimal threshold of 2.17 (79.0% sensitivity and 66.7% specificity). In contrast, TG\/HDL-C was not associated with fibrosis after adjustment (adjusted odds ratio, 0.84; 95% confidence interval, 0.63\u20131.10;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.209) and showed no discriminatory ability for fibrosis (area under the curve, 0.494).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TG\/HDL-C was independently associated with ultrasonographically detected hepatic steatosis and showed moderate discriminatory performance in patients with severe obesity undergoing evaluation for metabolic and bariatric surgery. However, it was not associated with fibrosis assessed by elastography. These findings support TG\/HDL-C as a potential low-cost adjunct for identifying steatosis, but not as a substitute for fibrosis-specific assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08891-z","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:23:05Z","timestamp":1787142185000},"page":"5164-5172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triglyceride-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but not Fibrosis in Patients with Severe Obesity: A Cross-Sectional Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Carolina","family":"de Oliveira Bernardes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6603-6944","authenticated-orcid":false,"given":"Esdras Marques","family":"Lins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Appolonio","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Kreimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Bessa Veloso","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataly Regina Fonseca Carvalho","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolyna Maria Lima","family":"de Medeiros Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro Antonio Bandeira","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"1","key":"8891_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02108-x","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024;23(1):117. https:\/\/doi.org\/10.1186\/s12944-024-02108-x.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"8891_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"3","key":"8891_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/apt.18451","volume":"61","author":"S Owrangi","year":"2025","unstructured":"Owrangi S, Paik JM, Golabi P, de Avila L, Hashida R, Nader A, et al. Meta-analysis: global prevalence and mortality of cirrhosis in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2025;61(3):433\u201343. https:\/\/doi.org\/10.1111\/apt.18451.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"8891_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"key":"8891_CR5","doi-asserted-by":"publisher","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology.\u00a02023;77(5):1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","DOI":"10.1097\/HEP.0000000000000323"},{"issue":"3","key":"8891_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390. https:\/\/doi.org\/10.1002\/hep.24452.","journal-title":"Hepatology"},{"issue":"6","key":"8891_CR7","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042.","journal-title":"Gastroenterology"},{"key":"8891_CR8","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol\u00a02021;75(3):659\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025","DOI":"10.1016\/j.jhep.2021.05.025"},{"issue":"7","key":"8891_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic dysfunction\u2013associated steatotic liver disease. N Engl J Med. 2025;393(7):683\u201398. https:\/\/doi.org\/10.1056\/NEJMra2412865.","journal-title":"N Engl J Med"},{"issue":"7","key":"8891_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"issue":"5","key":"8891_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000538765","volume":"17","author":"\u00c8 Navarro-Masip","year":"2024","unstructured":"Navarro-Masip \u00c8, Mestres Petit N, Salinas-Roca B, Herrer\u00edas F, Vilardell F, de la Fuente MC, et al. Metabolic dysfunction-associated steatotic liver disease in severe obesity and concordance between invasive (biopsy) and noninvasive (OWLiver\u00ae) diagnoses. Obes Facts. 2024;17(5):473\u201382. https:\/\/doi.org\/10.1159\/000538765.","journal-title":"Obes Facts"},{"key":"8891_CR12","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2025. Available from: https:\/\/www.R-project.org\/"},{"key":"8891_CR13","doi-asserted-by":"publisher","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119(9):1787\u20131798. https:\/\/doi.org\/10.1093\/cvr\/cvad095.","DOI":"10.1093\/cvr\/cvad095"},{"key":"8891_CR14","doi-asserted-by":"publisher","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883.","DOI":"10.1007\/BF00280883"},{"issue":"16","key":"8891_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15162045","volume":"15","author":"E Hoca","year":"2025","unstructured":"Hoca E, Cangir B, Ahbab S, \u015eahin SI, \u00d6zt\u00fcrk E\u00c7, Urvas\u0131zo\u011flu A\u00d6, et al. The triglyceride\/HDL ratio as a non-invasive marker for early-stage NAFLD: a retrospective cross-sectional study of 2588 patients. Diagnostics (Basel). 2025;15(16):2045. https:\/\/doi.org\/10.3390\/diagnostics15162045.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"8891_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2021.08.017","volume":"76","author":"LA van Kleef","year":"2022","unstructured":"van Kleef LA, Sonneveld MJ, de Man RA, de Knegt RJ. Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline. J Hepatol. 2022;76(1):245\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.017.","journal-title":"J Hepatol"},{"issue":"1","key":"8891_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11695-022-06380-7","volume":"33","author":"KJP Schwenger","year":"2023","unstructured":"Schwenger KJP, Alali M, Ghorbani Y, Fischer SE, Jackson TD, Okrainec A, et al. Reliability of non-invasive liver fibrosis assessment tools versus biopsy in pre- and post-bariatric surgery patients with non-alcoholic fatty liver disease. Obes Surg. 2023;33(1):247\u201355. https:\/\/doi.org\/10.1007\/s11695-022-06380-7.","journal-title":"Obes Surg"},{"key":"8891_CR18","doi-asserted-by":"publisher","unstructured":"Gasevic D, Frohlich J, Mancini GBJ, Lear SA. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism. 2012;61(4):583\u2013589. https:\/\/doi.org\/10.1016\/j.metabol.2011.09.009.","DOI":"10.1016\/j.metabol.2011.09.009"},{"issue":"5","key":"8891_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533\u201344. https:\/\/doi.org\/10.1530\/EJE-17-0883.","journal-title":"Eur J Endocrinol"},{"key":"8891_CR20","doi-asserted-by":"publisher","unstructured":"Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease: a systematic review and meta-analysis. Nutrients. 2022;14(23):4969. https:\/\/doi.org\/10.3390\/nu14234969.","DOI":"10.3390\/nu14234969"},{"key":"8891_CR21","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Montoro JI, Cornejo-Pareja I, Tinahones FJ, et al. Triglyceride to HDL cholesterol ratio for the identification of MASLD in obesity: a liver biopsy-based case-control study. Nutrients. 2024;16(9):1310. https:\/\/doi.org\/10.3390\/nu16091310.","DOI":"10.3390\/nu16091310"},{"key":"8891_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1362396","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Li H, Wang X, Shi R, Hu J, Zeng X, et al. Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017\u20132020. Front Endocrinol (Lausanne). 2024;15:1362396. https:\/\/doi.org\/10.3389\/fendo.2024.1362396.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8891_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82116-0","volume":"14","author":"L Bian","year":"2024","unstructured":"Bian L, Tang T, Yu Q, et al. Association between the triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus in non-alcoholic fatty liver disease. Sci Rep. 2024;14:31048. https:\/\/doi.org\/10.1038\/s41598-024-82116-0.","journal-title":"Sci Rep"},{"issue":"6","key":"8891_CR24","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","volume":"21","author":"F Tavaglione","year":"2023","unstructured":"Tavaglione F, Jamialahmadi O, De Vincentis A, et al. Development and validation of a score for fibrotic nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2023;21(6):1523-1532.e1. https:\/\/doi.org\/10.1016\/j.cgh.2022.03.044.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8891_CR25","doi-asserted-by":"publisher","unstructured":"Newsome PN, Sasso M, Deeks JJ, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5(4):362\u2013373. https:\/\/doi.org\/10.1016\/S2468-1253(19)30383-8.","DOI":"10.1016\/S2468-1253(19)30383-8"},{"issue":"4","key":"8891_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","volume":"76","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Truong E, Gornbein JA, et al. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. J Hepatol. 2022;76(4):781\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.012.","journal-title":"J Hepatol"},{"key":"8891_CR27","doi-asserted-by":"publisher","unstructured":"Taru MG, Tefas C, Neamti L, et al. FAST and Agile\u2014the MASLD drift: validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria. PLoS One. 2024;19(5):e0303971. https:\/\/doi.org\/10.1371\/journal.pone.0303971.","DOI":"10.1371\/journal.pone.0303971"},{"issue":"4","key":"8891_CR28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","volume":"159","author":"G Lassailly","year":"2020","unstructured":"Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159(4):1290-1301.e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.006.","journal-title":"Gastroenterology"},{"issue":"3","key":"8891_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11892-023-01498-z","volume":"23","author":"SF Noria","year":"2023","unstructured":"Noria SF, Shelby RD, Atkins KD, Nguyen NT, Gadde KM. Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment. Curr Diab Rep. 2023;23(3):31\u201342. https:\/\/doi.org\/10.1007\/s11892-023-01498-z.","journal-title":"Curr Diab Rep"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08891-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:19:10Z","timestamp":1791382750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08891-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8891"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08891-z","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional Human Research Ethics Committee do Hospital da Cl\u00ednicas da Universidade Federal de Pernambuco (approval no. 7,835,810; CAAE: 90542125.1.0000.8807). This research was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}